UPMC Heart Valve Symposium (HVS 2023)
The 2023 UPMC Heart Valve Symposium will provide an immersive and interactive experience into one of the most rapidly advancing and exciting spaces in cardiovascular medicine and surgery—heart valve disease. Experts from the UPMC Heart and Vascular Institute will explore the continuum of structural heart disease from diagnosis to work-up to intervention, with a focus on the lifelong management of heart valve disease. Interactive didactic, panel discussions, and moderated broadcast of 2 recorded live structural heart cases will provide a deep dive into the latest advancements and best-practice management strategies, including the cutting-edge of transcatheter heart valve repair and replacement, minimally invasive and robotic-assisted valve surgery, and advanced imaging techniques. This course will also look to what the future has in store—novel technologies, therapies, and clinical trials. All members of the multi-disciplinary heart team, current and future, are invited to join us as we do a deep dive into heart valve disease!
This meeting is open to physicians (including family practitioners, internists, residents, cardiologists, cardiac surgeons, thoracic surgeons, and anesthesiologists), advanced practice providers, nurses, researchers, medical students, and other health care professionals involved in the care of patients with complex valve and structural heart disease.
The UPMC Heart Valve Symposium intends to fulfill the following learning objectives:
• Increase understanding of screening, diagnosis, and treatment of aortic, mitral, and tricuspid valvular heart disease in various patient populations.
• Understand advanced modalities to image aortic, mitral, and tricuspid heart valves.
• Increase knowledge of medical therapies and transcatheter and/or surgical interventions for treatment of valvular heart disease, and the risks and benefits of the different therapeutic options.
• Enhance understanding of importance of the multi-disciplinary heart team approach to treatment of structural heart disease.
• Recognize impact of social determinants of health on structural heart disease outcomes.
• Conduct a deep dive into technical aspects of transcatheter and surgical interventions to manage aortic, mitral, and tricuspid heart valve disease.
• Explore landmark, recent and upcoming clinical trials, and their impact on heart valve disease
• Explore complex and challenging cases in structural heart disease patients and tactics and techniques for management.
Date and Time
8 a.m. to 2 p.m. Saturday, April 29, 2023
Ibrahim Sultan, MD
Associate Professor of Cardiothoracic Surgery
Surgical Director, UPMC Center for Heart Valve
Director, UPMC Center for Thoracic Aortic Disease
UPMC Heart and Vascular Institute
A.J. Conrad Smith, MD
Associate Professor of Medicine
Medical Director, UPMC Center for Heart Valve
Associate Chief of Cardiology for Diversity, Equity,
Director, Cardiac Catheterization Labs
UPMC Heart and Vascular Institute
Hemal Gada, MD
President, UPMC Heart and Vascular Institute at
Medical Director, Structural Heart Program
UPMC Heart and Vascular Institute, Central Pa.
This activity is approved for the following credit: AMA PRA Category 1 Credit™, ANCC, and AAPA Category 1 CME. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
- 0.25 AAPA Category I CME
- 0.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 0.25 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 0.25 Attendance
For more information, please contact Angela Kinnunen by email at firstname.lastname@example.org or phone 412-770-4949.